withdrawal trial
Showing 1 - 25 of >10,000
E-cigarette Use, Withdrawal Trial in Baltimore (Transdermal Nicotine Patch, Placebo Nicotine Patch)
Not yet recruiting
- E-cigarette Use
- Withdrawal
- Transdermal Nicotine Patch
- Placebo Nicotine Patch
-
Baltimore, MarylandBehavioral Pharmacology Research Unit
Sep 28, 2023
Opiate Withdrawal Syndrome, Opioid Use Trial in Philadelphia (LFX/PGB, LFX/PLA-PGB)
Not yet recruiting
- Opiate Withdrawal Syndrome
- Opioid Use
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, Treatment Research Center
Aug 18, 2023
Immune Tolerance, Immunosuppression, Liver Transplant; Complications Trial in Tianjin (Tacrolimus or Cyclosporine A)
Not yet recruiting
- Immune Tolerance
- +2 more
- Tacrolimus or Cyclosporine A
-
Tianjin, Tianjin, ChinaTianjin First Central Hospital
Nov 23, 2023
Opioid Withdrawal (Disorder) Trial (Standard of Care with Lofexidine, Standard of Care without Lofexidine)
Not yet recruiting
- Opioid Withdrawal (Disorder)
- Standard of Care with Lofexidine
- Standard of Care without Lofexidine
- (no location specified)
Sep 14, 2023
Heart Failure, Electric Impedance, Dyspnea Trial in Córdoba (Diuretics withdrawal, Diuretics maintenance)
Recruiting
- Heart Failure
- +4 more
- Diuretics withdrawal
- Diuretics maintenance
-
Córdoba, Córdoba (Andalucía), SpainHospital Universitario Reina Sofía
Jul 25, 2023
Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome Trial in Hershey (microRNA-146a level, microRNA-192 level,
Recruiting
- Neonatal Opioid Withdrawal Syndrome
- Neonatal Abstinence Syndrome
- microRNA-146a level
- +2 more
-
Hershey, PennsylvaniaPenn State Milton S. Hershey Medical Center
Jun 30, 2023
Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)
Not yet recruiting
- Opioid Use Disorder
- Opioid Withdrawal
- BXCL501 (180 micrograms)
- +3 more
- (no location specified)
Jan 24, 2023
Chronic Insomnia, Hypnotic Dependence Trial in Lausanne (Medium duration withdrawal programme with ACT, Long duration withdrawal
Active, not recruiting
- Chronic Insomnia
- Hypnotic Dependence
- Medium duration withdrawal programme with ACT
- +3 more
-
Lausanne, SwitzerlandPROSOM
Oct 13, 2022
Effective Withdrawal Time and Adenoma Detection Rate
Not yet recruiting
- Colonic Polyp
- +2 more
- Endoscreen QC
- (no location specified)
Sep 30, 2023
Sarcoidosis Trial (STOP arm)
Not yet recruiting
- Sarcoidosis
- STOP arm
- (no location specified)
Jan 16, 2023
Using Clonidine and/or Buprenorphine
Recruiting
- Withdrawal Syndrome
- Clonidine, Buprenorphine
-
Surrey, British Columbia, CanadaSalem Anaesthesia Pain Clinic
May 28, 2023
Opioid Use Disorder Trial (sphenopalatine ganglion block)
Not yet recruiting
- Opioid Use Disorder
- sphenopalatine ganglion block
- (no location specified)
Jan 3, 2023
Neonatal Abstinence Syndrome Trial in Charleston (Spark Biomedical Roo Transcutaneous Auricular Neurostimulation (tAN) System)
Completed
- Neonatal Abstinence Syndrome
- Spark Biomedical Roo Transcutaneous Auricular Neurostimulation (tAN) System
-
Charleston, South CarolinaMedical University of South Carolina
Dec 7, 2022
Withdrawal; Therapeutic Substance Trial in Houston (Clonidine (without protocolized initiation), Clonidine (protocolized
Recruiting
- Withdrawal; Therapeutic Substance
- Clonidine (without protocolized initiation)
- Clonidine (protocolized initiation)
-
Houston, TexasChildren's Memorial Hermann Hospital
Jan 24, 2023
Alcohol Withdrawal Trial in Copenhagen (Blood samples)
Recruiting
- Alcohol Withdrawal
- Blood samples
-
Copenhagen, DenmarkBispebjerg and Frederiksberg Hospital
Sep 28, 2022
Methamphetamine Use Disorder Trial in Richmond (Oxytocin nasal spray)
Not yet recruiting
- Methamphetamine Use Disorder
- Oxytocin nasal spray
-
Richmond, Victoria, AustraliaTurning Point
Mar 6, 2023
Opioid Use Disorder, Opioid Withdrawal, Opioid Craving Trial in Baltimore (Buspirone, Lofexidine, Placebo)
Not yet recruiting
- Opioid Use Disorder
- +3 more
- Buspirone
- +2 more
-
Baltimore, MarylandBehavioral Pharmacology Research Unit
Aug 19, 2022
Methadone vs. Transdermal Fentanyl for Opioid Withdrawal
Not yet recruiting
- Delirium in the Intensive Care Unit
- Administration of methadone instead of fentanyl patch
-
Kfar Saba, IsraelMeir medical center Kfar Saba
Jan 15, 2023
Opioid Use Disorder Trial in Wernersville (Bridge™ active device, Bridge™ sham device)
Enrolling by invitation
- Opioid Use Disorder
- Bridge™ active device
- Bridge™ sham device
-
Wernersville, PennsylvaniaCaron Treatment Centers
Jun 21, 2023
Glucocorticoid Withdrawal Syndrome in Treated Cushing Syndrome
Recruiting
- Cushing Syndrome
- MUSE biofeedback
-
Rochester, MinnesotaMayo Clinic
Oct 31, 2022
Heart Failure With Reduced Ejection Fraction, Heart Rhythm Disorder Trial (GDMT)
Not yet recruiting
- Heart Failure With Reduced Ejection Fraction
- Heart Rhythm Disorder
- (no location specified)
Nov 9, 2023
Kratom Product Effects Among Regular Consumers
Not yet recruiting
- Withdrawal Symptoms
- Effects from acute kratom exposure
- (no location specified)
Oct 20, 2023
Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)
Recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- Withdrawal;Drug
- Imatinib withdrawal
- +2 more
-
Brno, Czechia
- +7 more
Aug 24, 2022
T-bet B Cells in Persistent Virus Control After Discontinuance
Completed
- Chronic HBV Infection
- Drug Withdrawal
- T-bet B cell
-
Shanghai, ChinaChanghai hospital
Sep 1, 2023